Commentary

Exome Sequencing Opens a New Chapter in CKD

By

Anthony Bleyer, MD

Publish Date February 1, 2019

Study results point to a future when whole exome sequencing will be the method of choice for identifying genetic causes of CKD.

The Rapidly Evolving Landscape for mRCC

By

Benjamin T. Ristau, MD; Robert G. Uzzo, MD, FACS

Publish Date December 10, 2018

Incredible progress is being made in kidney cancer treatment.

Is ESCO the Future of Dialysis Care?

By

Kam Kalantar-Zadeh, MD, MPH, PhD

Publish Date October 12, 2018

ESCOs are accountable for clinical quality outcomes and financial outcomes.

The Growing Challenge of Advanced Prostate Cancer Clinics

By

Bryan A. Mehlhaff, MD

Publish Date October 5, 2018

With an ever-expanding array of options for treating advanced prostate cancer, it is important to remain focused on the best treatment path for each patient.

Rising China and Modern Medicine for Over 1 Billion

By

Benjamin T. Ristau, MD; Robert G. Uzzo, MD, FACS

Dan Zhang, President, Champions of Medical Advancement Associates

Publish Date August 10, 2018

Several years ago, I was asked to performa virtual consult on a 48-yearoldChinese business man with acomplex hilar tumor in a solitary kidney.He was advised by some of the best specialistsin his country that the only option wasnephrectomy and hemodialysis. Four yearsafter successful nephron preservation andrecuperation at our center, I visited himand his country. Together,…

Longer Dialysis Time and Patient Suffering

By

Kam Kalantar-Zadeh, MD, MPH, PhD

Publish Date May 25, 2018

CMS also has upcoming plans to impose fiscal penalties related to dialysis treatment.

Prostate Cancer Survival Metrics: A New Standard?

By

Benjamin T. Ristau, MD; Robert G. Uzzo, MD, FACS

Publish Date March 24, 2018

Effective clinical trial design and ultimately drug approval require careful consideration of the endpoints selected.

Guidelines Disconnect: Patients’ Voice Absent

By

Kam Kalantar-Zadeh, MD, MPH, PhD

Publish Date January 9, 2018

Patient-centeredness should become a core component of clinical practice guidelines, according to Dr Kalantar-Zadeh.

The Adrenal Gland: The Forgotten Urologic Organ

By

Benjamin T. Ristau, MD; Robert G. Uzzo, MD, FACS

Publish Date December 12, 2017

The adrenal glands are easilyoverlooked. Distinguishedanatomists from centuries agosuch as Aelius Galen, Leonardo daVinci, and Andreas Vesalius omittedthe adrenals in their early descriptionsof the retroperitoneum. The criticalimportance of the adrenal gland wasrecognized in the mid-19th centuryby Thomas Addison and CharlesÉdouardBrown-Séquard, who demonstratedthat bilateral adrenalectomyuniformly resulted in death. This ledto the discovery and isolation of adrenaline,…

Nephrology-Urology Teamwork Sensible

By

Kam Kalantar-Zadeh, MD, MPH, PhD

Publish Date October 6, 2017

A number of patients referred to my faculty ambulatory clinic at the University of California Irvine have urologic disorders, including some who underwent partial or radical nephrectomy. Many patients do not comprehend the distinction between nephrologist and urologist, and refer to both as “kidney doctor.” I often educate these patients, explaining that a urologist is…